521 related articles for article (PubMed ID: 27120445)
1. International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances.
Jacobs MN; Colacci A; Louekari K; Luijten M; Hakkert BC; Paparella M; Vasseur P
ALTEX; 2016; 33(4):359-392. PubMed ID: 27120445
[TBL] [Abstract][Full Text] [Related]
2. Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens.
Jacobs MN; Colacci A; Corvi R; Vaccari M; Aguila MC; Corvaro M; Delrue N; Desaulniers D; Ertych N; Jacobs A; Luijten M; Madia F; Nishikawa A; Ogawa K; Ohmori K; Paparella M; Sharma AK; Vasseur P
Arch Toxicol; 2020 Aug; 94(8):2899-2923. PubMed ID: 32594184
[TBL] [Abstract][Full Text] [Related]
3. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
5. Analyses of Transcriptomics Cell Signalling for Pre-Screening Applications in the Integrated Approach for Testing and Assessment of Non-Genotoxic Carcinogens.
Oku Y; Madia F; Lau P; Paparella M; McGovern T; Luijten M; Jacobs MN
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361516
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
Osimitz TG; Droege W; Boobis AR; Lake BG
Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
[TBL] [Abstract][Full Text] [Related]
8. A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
Petkov PI; Patlewicz G; Schultz TW; Honma M; Todorov M; Kotov S; Dimitrov SD; Donner EM; Mekenyan OG
Regul Toxicol Pharmacol; 2015 Jun; 72(1):17-25. PubMed ID: 25792138
[TBL] [Abstract][Full Text] [Related]
9. An integrative test strategy for cancer hazard identification.
Luijten M; Olthof ED; Hakkert BC; Rorije E; van der Laan JW; Woutersen RA; van Benthem J
Crit Rev Toxicol; 2016 Aug; 46(7):615-39. PubMed ID: 27142259
[TBL] [Abstract][Full Text] [Related]
10. Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?
Doktorova TY; Pauwels M; Vinken M; Vanhaecke T; Rogiers V
Crit Rev Toxicol; 2012 Feb; 42(2):91-106. PubMed ID: 22141324
[TBL] [Abstract][Full Text] [Related]
11. In Vitro-In Vivo Carcinogenicity.
Steinberg P
Adv Biochem Eng Biotechnol; 2017; 157():81-96. PubMed ID: 27506831
[TBL] [Abstract][Full Text] [Related]
12. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
14. Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.
Desaulniers D; Vasseur P; Jacobs A; Aguila MC; Ertych N; Jacobs MN
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681626
[TBL] [Abstract][Full Text] [Related]
15. A perspective on current and future uses of alternative models for carcinogenicity testing.
Goodman JI
Toxicol Pathol; 2001; 29 Suppl():173-6. PubMed ID: 11695554
[TBL] [Abstract][Full Text] [Related]
16. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
17. Neonatal mouse model: review of methods and results.
McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
[TBL] [Abstract][Full Text] [Related]
18. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
19. Dynamically monitoring cellular γ-H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds.
Qu M; Xu H; Li W; Chen J; Zhang Y; Xu B; Li Z; Liu T; Guo L; Xie J
Arch Toxicol; 2021 Nov; 95(11):3559-3573. PubMed ID: 34510228
[TBL] [Abstract][Full Text] [Related]
20. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results.
Kirkland DJ; Aardema M; Banduhn N; Carmichael P; Fautz R; Meunier JR; Pfuhler S
Mutagenesis; 2007 May; 22(3):161-75. PubMed ID: 17369606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
